Xencor (XNCR) Amortizatization of Intangibles (2015 - 2026)
Xencor's (XNCR) quarterly Amortizatization of Intangibles came in at $128000.0 in Q1 2026, down 93.98% year-on-year from $2.1 million in Q1 2025, and down 62.35% on a QoQ basis from $340000.0 in Q4 2025.
Xencor (XNCR) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
Xencor (XNCR) has 12 years of Amortizatization of Intangibles data on file, last reported at $128000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 93.98% year-over-year to $128000.0 in Q1 2026; TTM through Mar 2026 was $1.5 million, a 86.83% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 78.3% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $128000.0, down from $340000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for XNCR reached as high as $6.9 million in Q1 2024 and fell as low as -$637000.0 in Q2 2025.
- Historically, Amortizatization of Intangibles has averaged $2.0 million across 5 years, with a median of $1.7 million in 2025.
- Across the five-year window, Amortizatization of Intangibles soared 6452.54% in 2023 and slumped 113.19% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $782000.0 in 2022, then surged by 593.61% to $5.4 million in 2023, then tumbled by 110.9% to -$591000.0 in 2024, then jumped by 157.53% to $340000.0 in 2025, then plunged by 62.35% to $128000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $128000.0 in Q1 2026, $340000.0 in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Xencor | 1.49 Bn | 1.11 Bn | - | 128,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128,000.00 |
| Mar 31, 2026 | 128,000.00 |
| Dec 31, 2025 | 340,000.00 |
| Dec 31, 2025 | 340,000.00 |
| Sep 30, 2025 | 1.65 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | -637,000.00 |
| Jun 30, 2025 | -637,000.00 |
| Mar 31, 2025 | 2.13 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | -591,000.00 |
| Dec 31, 2024 | -591,000.00 |
| Sep 30, 2024 | 4.89 Mn |
| Sep 30, 2024 | 4.89 Mn |
| Jun 30, 2024 | 4.83 Mn |
| Jun 30, 2024 | 4.83 Mn |
| Mar 31, 2024 | 6.91 Mn |
| Mar 31, 2024 | 6.91 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Dec 31, 2023 | 5.42 Mn |